|
| 37162990 | CD3[+] T-cell: CD14[+]monocyte complexes are dynamic and increased with HIV and glucose intolerance. | bioRxiv | 2024 |
| 37516359 | Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis. | J Am Acad Dermatol | 2024 |
| 37516356 | Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management. | J Am Acad Dermatol | 2024 |
| 36384652 | Advances in the Understanding of Drug Hypersensitivity: 2012 Through 2022. | J Allergy Clin Immunol Pract | 2023 |
| 37805007 | Drug Allergy in Women. | J Allergy Clin Immunol Pract | 2023 |
| 37459086 | Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy: The PALACE Randomized Clinical Trial. | JAMA Intern Med | 2023 |
| 37214159 | Long-term HIV and tuberculosis outcomes in patients hospitalised with severe cutaneous adverse reactions. | J Clin Tuberc Other Mycobact Dis | 2023 |
| 37414339 | An Update in COVID-19 Vaccine Reactions in 2023: Progress and Understanding. | J Allergy Clin Immunol Pract | 2023 |
| 37273210 | Development and Validation of a Sulfa Antibiotic Allergy Clinical Decision Rule. | JAMA Netw Open | 2023 |
| 37233764 | Association between atopic dermatitis, autoimmune illnesses, Epstein-Barr virus, and cytomegalovirus. | Arch Dermatol Res | 2023 |
| 37295474 | Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach. | J Allergy Clin Immunol | 2023 |
| 36549954 | HIV-Associated Immune Dysregulation in the Skin: A Crucible for Exaggerated Inflammation and Hypersensitivity. | J Invest Dermatol | 2023 |
| 36814255 | Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus. | Orphanet J Rare Dis | 2023 |
| 36720995 | Association of KIR2DL5, KIR2DS5, and KIR2DS1 allelic variation and atopic dermatitis. | Sci Rep | 2023 |
| 36844223 | First-line therapy in drug reaction with eosinophilia and systemic symptoms (DReSS): Thinking beyond corticosteroids. | Front Med (Lausanne) | 2023 |
| 36740326 | Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions. | J Allergy Clin Immunol | 2023 |
| 36637513 | KIR Allelic Variation and the Remission of Atopic Dermatitis Over Time. | Immunohorizons | 2023 |
| 36941915 | Physical and mental health impact of Stevens-Johnson syndrome/toxic epidermal necrolysis and post-hospital discharge care: Identifying practice gaps. | JAAD Int | 2023 |
| 36563781 | Drug Allergy Practice Parameter Updates to Incorporate Into Your Clinical Practice. | J Allergy Clin Immunol Pract | 2023 |
| 36728247 | Human Leukocyte Antigen Genotyping of Idiopathic Subglottic Stenosis. | Laryngoscope | 2023 |
| 36630118 | Drug Reaction With Eosinophilia and Systemic Symptoms. | JAMA Dermatol | 2023 |
| 36790777 | Worldwide Prevalence of Antibiotic-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis. | JAMA Dermatol | 2023 |
| 36373948 | Expression of specific HLA class II alleles is associated with an increased risk for active tuberculosis and a distinct gene expression profile. | HLA | 2023 |
| 36108922 | Clinical Phenotypes of Immediate First-Dose Reactions to mRNA COVID-19: A Multicenter Latent Class Analysis. | J Allergy Clin Immunol Pract | 2023 |
| 36100133 | Risk-stratified management to remove low-risk penicillin allergy labels in the patients with COVID-19 in the intensive care unit. | J Allergy Clin Immunol Pract | 2023 |
| 34400337 | Garcinia cambogia, Either Alone or in Combination With Green Tea, Causes Moderate to Severe Liver Injury. | Clin Gastroenterol Hepatol | 2022 |
| 35809990 | Precision Medicine in Allergy and Immunology Through the Lens of Immunogenomics. | J Allergy Clin Immunol Pract | 2022 |
| 35550878 | Adverse Events and Safety of SARS-CoV-2 Vaccines: What's New and What's Next. | J Allergy Clin Immunol Pract | 2022 |
| 35353440 | Oncologist counseling practice and COVID-19 vaccination outcomes for patients with history of PEG-asparaginase hypersensitivity. | Pediatr Blood Cancer | 2022 |
| 35353140 | Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis-Coordinating Research Priorities to Move the Field Forward. | JAMA Dermatol | 2022 |
| 35377938 | ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia. | Blood | 2022 |
| 35765165 | Safety and value of pretransplant antibiotic allergy delabeling in a quaternary transplant center. | Transpl Infect Dis | 2022 |
| 35344217 | Addressing beta-lactam allergy: A time for action. | Allergy | 2022 |
| 35700153 | Drug reaction with eosinophilia and systemic symptoms in patients hospitalized with COVID-19: a case series from a large US healthcare system. | Br J Dermatol | 2022 |
| 35469630 | Drug Hypersensitivity: A Glass Half Full. | Immunol Allergy Clin North Am | 2022 |
| 35469616 | Recognizing Drug Hypersensitivity in Pigmented Skin. | Immunol Allergy Clin North Am | 2022 |
| 35533259 | Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia. | Blood Adv | 2022 |
| 35393599 | Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines. | Nat Nanotechnol | 2022 |
| 35526777 | Practical Implementation of Genetics: New Concepts in Immunogenomics to Predict, Prevent, and Diagnose Drug Hypersensitivity. | J Allergy Clin Immunol Pract | 2022 |
| 35659939 | IFN-γ ELISpot in Severe Cutaneous Adverse Reactions to First-Line Antituberculosis Drugs in an HIV Endemic Setting. | J Invest Dermatol | 2022 |
| 35390476 | What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later. | Ann Allergy Asthma Immunol | 2022 |
| 35968750 | A low-cost, sensitive and specific PCR-based tool for rapid clinical detection of HLA-B*35 alleles associated with delayed drug hypersensitivity reactions. | HLA | 2022 |
| 36036421 | Advances in immunoglobulin E mediated antibiotic allergy. | Curr Opin Pediatr | 2022 |
| 35988972 | Where to place etanercept and combination treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis? | Ann Allergy Asthma Immunol | 2022 |
| 36091694 | Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020. | Front Med (Lausanne) | 2022 |
| 35977774 | Study protocol: Australasian Registry of Severe Cutaneous Adverse Reactions (AUS-SCAR). | BMJ Open | 2022 |
| 36151034 | Allergy Electronic Health Record Documentation: A 2022 Work Group Report of the AAAAI Adverse Reactions to Drugs, Biologicals, and Latex Committee. | J Allergy Clin Immunol Pract | 2022 |
| 35131513 | Low-risk penicillin allergy delabeling through a direct oral challenge in immunocompromised and/or multiple drug allergy labeled patients in a critical care setting. | J Allergy Clin Immunol Pract | 2022 |
| 35013250 | Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension. | Nat Commun | 2022 |
| 34979336 | Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy. | J Allergy Clin Immunol Pract | 2022 |